REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Caliway Biopharmaceuticals Co., Ltd. (Taiwan, China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Caliway Biopharmaceuticals Co., Ltd. Profile Updated: March 30, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

Caliway Biopharmaceuticals Co., Ltd. is engaged in breakthrough medical aesthetics and inflammatory medicine discovery of small-molecule therapeutics. The company’s main products include medical aesthetics and inflammatory medicine. The company was established in 2012 and is headquartered in New Taipei City, Taiwan.

Headquarters
32F-9, No.99, Sec. 1, Xintai 5Th Rd, Xizhi Dist
New Taipei City; New Taipei City;

Contact Details: Purchase the Caliway Biopharmaceuticals Co., Ltd. report to view the information.

Website: http://www.caliway.com.tw

Basic Information
Total Employees:
Purchase the Caliway Biopharmaceuticals Co., Ltd. report to view the information.
Outstanding Shares:
Purchase the Caliway Biopharmaceuticals Co., Ltd. report to view the information.
Financial Auditors:
Purchase the Caliway Biopharmaceuticals Co., Ltd. report to view the information.
Incorporation Date:
October 22, 2012
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
12.49%
Purchase this report to view the information.
8.8%
Purchase this report to view the information.
1.46%
Purchase this report to view the information.
1.38%
Purchase this report to view the information.
Subsidiaries
Cailway (Usa)Co.,Ltd (United States)
100%
Caliway Biopharmaceuticals Australia Pty Ltd (Australia)
100%
Company Performance
Financial values in the chart are available after Caliway Biopharmaceuticals Co., Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TWD. Absolute financial data is included in the purchased report.
Net sales revenue
203.68%▲
Total operating revenue
275.41%▲
Operating profit (EBIT)
-57.79%▼
EBITDA
-83.13%▼
Net Profit (Loss) for the Period
-70.7%▼
Total assets
210.32%▲
Total equity
221.32%▲
Operating Profit Margin (ROS)
1197.72%▲
Net Profit Margin
977.46%▲
Return on Equity (ROE)
11.52%▲
Quick Ratio
27.45%▲
Cash Ratio
32.9%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo